Check back frequently for the latest updates.
Mass General Brigham Health Plan is committed to providing our members with access to high-quality health care that is consistent with evidence-based, nationally recognized clinical criteria and guidelines. Therefore, we will be implementing a change in the way we manage certain specialty drugs that fall under the medical benefit. This new program will be administered by the Medical Pharmacy Solutions team at Prime Therapeutics (Prime).
Beginning December 22, 2025, providers should begin contacting Prime to obtain prior authorizations via web, fax, or phone or the in-scope drugs for our members with dates of service on or after January 1, 2026. Please note the drugs considered in-scope vary by member plan.
The program will apply to the following plans*:
*The Medicare Part D Group PDP is not included in this program as this plan does not have Part B medical drug coverage.
Although the effective date of this program is January 1, 2026, providers can begin submitting prior authorizations to Prime on December 22, 2025, for dates of service January 1, 2026, or later.
Lists of the medications reviewed by Prime can be found on the following sites:
Prime will only manage reviews for drugs that fall under the medical benefit for the plans listed above. For information on how to submit coverage requests to Optum Rx beginning January 1, 2026 or later for drugs that fall under the pharmacy benefit, please refer to https://MGBHP.org/providers/pharmacy-guidelines for Commercial and Medicaid and MGBAdvantage.org for Medicare Advantage (including SCO and One Care).
For Commercial/QHP and MassHealth, specialty medications obtained through the pharmacy benefit that were previously reviewed by Specialty Fusion will be reviewed by Optum Rx effective January 1, 2026.
Yes, in addition to routine updates, our Commercial/QHP plans will implement Prime drug policies. For further details, please consult the upcoming Provider Newsletter. Medicare Advantage (including SCO and One Care) will use CMS’ NCDs and LCDs.
Policies for MGBHP’s plans can be found on the following sites:
For more information about prior authorizations, providers can call the Medical Pharmacy Solutions team at Prime Therapeutics (Prime) at 833-895-2611.
Providers directly contracted with MGBHP may request urgent and non-urgent authorizations on the Prime secure provider portal at www.GatewayPA.com. Providers may also call Prime for urgent authorization requests at 833-895-2611. Hours of operation are 8 a.m. – 8 p.m. for routine requests, and 24 hours per day/7 days per week for urgent requests.
To expedite prior authorizations, the provider should have the following information:
If requested by Prime, the provider should be prepared to upload the following documents to the Prime provider portal, or to fax the following documents to Prime’s HIPAA-compliant fax:
Please note: It is the responsibility of the ordering provider to obtain prior authorization before services are provided. If the ordering provider and the rendering provider are different, the rendering provider is responsible for ensuring that the appropriate approval is on file prior to rendering services.
Providers directly contracted with MGB may request access to the Prime provider portal. To do so, visit Prime’s provider portal at www.GatewayPA.com and complete the following steps:
Please have the following information ready:
Please allow up to two business days for a response by email.
No. Prime provider portal users linked to the practice TIN will be able to conduct transactions for every network clinician linked to the practice TIN.
Providers and their staff will have the opportunity to obtain prior authorizations to help streamline medication administration and service.
Note: Prime initial clinical reviewers are clinical pharmacists.
Yes. In most cases, approvals can be made based on the initial information provided to Prime by the requestor. If there is a question or concern regarding the information provided, the case will be sent to a pharmacist who will reach out to the requesting provider. If the pharmacist cannot reach an agreement regarding the appropriate course of treatment with respect to the requested medication, the case will be escalated to a Prime physician. A Prime physician will discuss the case with the provider. They will make a mutual decision, in accordance with plan guidelines, on an appropriate course of action.
The ordering provider, rendering provider (if different from ordering) and member receive copies of the final determination notices.
The outpatient facility will receive a copy of the approval letter and can view the status of the approval via Prime’s provider portal www.GatewayPA.com.
After an approval is generated, a change in dose and/or frequency may be requested via phone at 833-895-2611 (preferred) or via fax at 888-656-6671. Retroactive requests may also be requested via phone at 833-895-2611 (preferred) or via fax at 888-656-6671.
There is one prior authorization number per medication. However, Prime can process multiple requests via a single portal session or telephone call.
Authorizations issued by MGBHP for dates of service before 1/1/2026, for the medications included in this program will be effective until the authorization end date. To continue treatment after the original authorization end date, you must obtain an authorization from Prime prior to the expiration date.
It is recommended that you reserve your spot in one of these education sessions at least one week ahead of time. You will receive a registration confirmation email from Prime for the webinar session you select, including instructions for dialing in by phone should you need to do so. You will only need to attend one of the below educational sessions.
Date | Time | Registration |
Wednesday, November 19, 2025 | 9-10 a.m. (EST) | https://bit.ly/3G5MF7m |
Wednesday, November 19, 2025 | 1-2 p.m. (EST) | https://bit.ly/4lawVzm |
Wednesday, December 3, 2025 | 9-10 a.m. (EST) | https://bit.ly/3I8Q0mX |
Wednesday, December 3, 2025 | 1- 2 p.m. (EST) | https://bit.ly/40tnwui |
Be the first to get the latest news, tips, and information when you subscribe to our provider Administrative Newsletter.